MedPath

Feasibility study on detecting EGFR T790M mutation in cell free DNA from advanced non small cell lung cancer patients refractory to EGFR-TKI:WJOG8014LTR

Not Applicable
Conditions
Advanced non-small cell lung cancer with EGFR mutation
Registration Number
JPRN-UMIN000015461
Lead Sponsor
West Japan Oncology Group
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
155
Inclusion Criteria

Not provided

Exclusion Criteria

Not applicable

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
feasibility of detecting EGFR T790M mutation in cell free DNA from advanced non small cell lung cancer patients refractory to EGFR-TKI
Secondary Outcome Measures
NameTimeMethod
detection rate of EGFR T790M mutations in plasma concordance of EGFR mutation status between tissue sample and plasma correlation between EGFR mutation status and clinical background
© Copyright 2025. All Rights Reserved by MedPath